Singapore legislation

Regulation 21C

of Central Provident Fund (Medisave Account Withdrawals) Regulations 2001

Regulation 21C

Additional withdrawal for treatment, etc., received as out‑patient

Subregulation 1

Subject to the withdrawal limit specified in regulation 21D, a member may withdraw moneys from the member’s medisave account to pay for any of the following received, on or after 1 April 2015, by the member or the member’s spouse as an out‑patient if the conditions in paragraph (2) are satisfied:

(a)

any of the following:

(i)

any treatment of neoplasms by chemotherapy mentioned in regulation 13(2) as in force immediately before 1 July 2017;

(ii)

any First Schedule treatment (other than a cancer scan or diagnostic test) provided by an approved medical practitioner in an approved hospital, approved centre or approved clinic;

(iii)

any cancer scan or diagnostic test ordered by an approved medical practitioner and provided in an approved medical institution;

(iv)

any Third Schedule treatment provided by an approved medical practitioner in an approved Third Schedule treatment provider;

(b)

any out‑patient scan mentioned in regulation 13A(1);

(c)

any approved chronic illness treatment mentioned in regulation 14(1);

(d)

any approved vaccination mentioned in regulation 14A(1);

(e)

any approved screening mentioned in regulation 14B(1);

(f)

any renal dialysis treatment mentioned in regulation 19(2);

(g)

any approved out‑patient parenteral nutrition mentioned in regulation 9B(1);

(h)

any repetitive transcranial magnetic stimulation treatment mentioned in regulation 13C(1);

(i)

any CTGTP treatment mentioned in regulation 13D(1);

(j)

any high‑cost drug treatment mentioned in regulation 13E(1).

Subregulation 2

The conditions for withdrawal of moneys under paragraph (1) are —

(a)

where the out‑patient is the member —

(i)

the member has attained the eligible age at the time the member receives the treatment, scan, test, vaccination or screening mentioned in paragraph (1)(a), (b), (c), (d), (e), (f), (h), (i) or (j) or the approved out‑patient parenteral nutrition mentioned in paragraph (1)(g), as the case may be; and

(ii)

the member receives the treatment, scan, test, vaccination or screening mentioned in paragraph (1)(a), (b), (c), (d), (e), (f), (h), (i) or (j) or the approved out‑patient parenteral nutrition mentioned in paragraph (1)(g) (as the case may be) other than as part of an approved treatment package; and

(b)

where the out‑patient is the member’s spouse —

(i)

the member and the member’s spouse have both attained the eligible age at the time the member’s spouse receives the treatment, scan, test, vaccination or screening mentioned in paragraph (1)(a), (b), (c), (d), (e), (f), (h), (i) or (j) or the approved out‑patient parenteral nutrition mentioned in paragraph (1)(g), as the case may be; and

(ii)

the member’s spouse receives the treatment, scan, test, vaccination or screening mentioned in paragraph (1)(a), (b), (c), (d), (e), (f), (h), (i) or (j) or the approved out‑patient parenteral nutrition mentioned in paragraph (1)(g) (as the case may be) other than as part of an approved treatment package.

Subregulation 3

To avoid doubt, any amount that may be withdrawn under paragraph (1) is in addition to any amount that may be withdrawn in accordance with the withdrawal limits specified in regulations 9B, 13, 13A, 13C, 13D, 13E, 14, 14A, 14B, 14C and 19 (as the case may be) for the relevant treatment, scan, test, vaccination or screening, or approved out‑patient parenteral nutrition, mentioned in paragraph (1).

Subregulation 4

In paragraph (2), “eligible age” means —

(a)

in relation to any treatment, scan, test, vaccination or screening, or approved out‑patient parenteral nutrition, received on or after 1 April 2015 but before 1 June 2018 — 65 years of age or older; and

(b)

in relation to any treatment, scan, test, vaccination or screening, or approved out‑patient parenteral nutrition, received on or after 1 June 2018 — 60 years of age or older.